219 related articles for article (PubMed ID: 19352388)
21. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma.
El-Gohary YM; Silverman JF; Olson PR; Liu YL; Cohen JK; Miller R; Saad RS
Am J Clin Pathol; 2007 Apr; 127(4):572-9. PubMed ID: 17369132
[TBL] [Abstract][Full Text] [Related]
22. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
23. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas.
Di Lieto A; De Falco M; Pollio F; Mansueto G; Salvatore G; Somma P; Ciociola F; De Rosa G; Staibano S
J Soc Gynecol Investig; 2005 Feb; 12(2):123-8. PubMed ID: 15695108
[TBL] [Abstract][Full Text] [Related]
24. Expression of growth factors in the conjunctiva from patients with active trachoma.
Abu El-Asrar AM; Al-Kharashi SA; Missotten L; Geboes K
Eye (Lond); 2006 Mar; 20(3):362-9. PubMed ID: 15818386
[TBL] [Abstract][Full Text] [Related]
25. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma.
Saad RS; El-Gohary Y; Memari E; Liu YL; Silverman JF
Hum Pathol; 2005 Sep; 36(9):955-61. PubMed ID: 16153457
[TBL] [Abstract][Full Text] [Related]
26. The associations between serum VEGF, bFGF and endoglin levels with microvessel density and expression of proangiogenic factors in malignant and benign ovarian tumors.
Szubert S; Moszynski R; Michalak S; Nowicki M; Sajdak S; Szpurek D
Microvasc Res; 2016 Sep; 107():91-6. PubMed ID: 27312585
[TBL] [Abstract][Full Text] [Related]
27. mRNA expression of the angiogenesis markers VEGF and CD105 (endoglin) in human breast cancer.
Gómez-Esquer F; Agudo D; Martínez-Arribas F; Nuñez-Villar MJ; Schneider J
Anticancer Res; 2004; 24(3a):1581-5. PubMed ID: 15274325
[TBL] [Abstract][Full Text] [Related]
28. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of neovascularisation in atherosclerotic plaques using CD31, CD105 and TGF beta 1.
Li C; Mollahan P; Baguneid MS; McMahon RF; Kumar P; Walker MG; Freemont AJ; Kumar S
Pathobiology; 2006; 73(4):192-7. PubMed ID: 17119348
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features.
Nair S; Nayak R; Bhat K; Kotrashetti VS; Babji D
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):35-41. PubMed ID: 25710582
[TBL] [Abstract][Full Text] [Related]
31. Expression of angiogenesis-stimulating factors (VEGF, CD31, CD105) and angiogenetic index in gingivae of patients with chronic periodontitis.
Kasprzak A; Surdacka A; Tomczak M; Przybyszewska W; Seraszek-Jaros A; Malkowska-Lanzafame A; Siodla E; Kaczmarek E
Folia Histochem Cytobiol; 2012; 50(4):554-64. PubMed ID: 23264219
[TBL] [Abstract][Full Text] [Related]
32. RhoC, vascular endothelial growth factor and microvascular density in esophageal squamous cell carcinoma.
Zhao ZH; Tian Y; Yang JP; Zhou J; Chen KS
World J Gastroenterol; 2015 Jan; 21(3):905-12. PubMed ID: 25624724
[TBL] [Abstract][Full Text] [Related]
33. Endoglin (CD105) expression in endometrial carcinoma.
Saad RS; Jasnosz KM; Tung MY; Silverman JF
Int J Gynecol Pathol; 2003 Jul; 22(3):248-53. PubMed ID: 12819391
[TBL] [Abstract][Full Text] [Related]
34. Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma.
Li SL; Gao DL; Zhao ZH; Liu ZW; Zhao QM; Yu JX; Chen KS; Zhang YH
World J Gastroenterol; 2007 Dec; 13(45):6076-81. PubMed ID: 18023103
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic significance of CD105 expression in squamous cell carcinoma of the hypopharynx.
Chien CY; Su CY; Hwang CF; Chuang HC; Hsiao YC; Wu SL; Huang CC
Head Neck; 2006 May; 28(5):441-6. PubMed ID: 16320363
[TBL] [Abstract][Full Text] [Related]
36. CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma.
Smith SJ; Tilly H; Ward JH; Macarthur DC; Lowe J; Coyle B; Grundy RG
Acta Neuropathol; 2012 Jul; 124(1):99-110. PubMed ID: 22311740
[TBL] [Abstract][Full Text] [Related]
37. Role of VEGF, CD105, and CD31 in the Prognosis of Colorectal Cancer Cases.
Mohamed SY; Mohammed HL; Ibrahim HM; Mohamed EM; Salah M
J Gastrointest Cancer; 2019 Mar; 50(1):23-34. PubMed ID: 29110224
[TBL] [Abstract][Full Text] [Related]
38. Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma.
Kyzas PA; Agnantis NJ; Stefanou D
Virchows Arch; 2006 Jun; 448(6):768-75. PubMed ID: 16612622
[TBL] [Abstract][Full Text] [Related]
39. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
Behrem S; Zarkovic K; Eskinja N; Jonjic N
Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521
[TBL] [Abstract][Full Text] [Related]
40. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
